Skip to content
10-Q

Quarterly Report

POINT BIOPHARMA GLOBAL INC.

0001811764-23-000046

← back to feed
Filed
Nov 13, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 8, 2023 106.57M sh
Shares Diluted Q3 2023 · Sep 30, 2023 105.77M sh
Shares Diluted Q3 2023 · Sep 30, 2023 105.72M sh
Shares Diluted Q3 2023 · Sep 30, 2022 92.4M sh
Shares Diluted Q3 2023 · Sep 30, 2022 90.89M sh
Dividends Paid Q3 2023 · Sep 30, 2023 $0
Dividends Paid Q3 2023 · Sep 30, 2023 $0
Dividends Paid Q3 2023 · Sep 30, 2022 $0
Dividends Paid Q3 2023 · Sep 30, 2022 $0
Capex Q3 2023 · Sep 30, 2023 $17.25M
Capex Q3 2023 · Sep 30, 2022 $10.7M
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$124.86M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$53.4M
Short Term Investments Q3 2023 · Sep 30, 2023 $317.56M
Short Term Investments Q3 2023 · Dec 31, 2022 $238.78M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $21.61M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $286.43M
Current Liabilities Q3 2023 · Sep 30, 2023 $38.67M
Current Liabilities Q3 2023 · Dec 31, 2022 $79.74M
Total Liabilities Q3 2023 · Sep 30, 2023 $53.51M
Total Liabilities Q3 2023 · Dec 31, 2022 $91.37M
Current Assets Q3 2023 · Sep 30, 2023 $353.25M
Current Assets Q3 2023 · Dec 31, 2022 $530.82M
Total Assets Q3 2023 · Sep 30, 2023 $477.7M
Total Assets Q3 2023 · Dec 31, 2022 $578.32M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.23
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.63
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.26
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.71
Eps Basic Q3 2023 · Sep 30, 2023 −$0.23
Eps Basic Q3 2023 · Sep 30, 2023 −$0.63
Eps Basic Q3 2023 · Sep 30, 2022 −$0.26
Eps Basic Q3 2023 · Sep 30, 2022 −$0.71
Sga Expense Q3 2023 · Sep 30, 2023 $5.51M
Sga Expense Q3 2023 · Sep 30, 2023 $15.6M
Sga Expense Q3 2023 · Sep 30, 2022 $3.84M
Sga Expense Q3 2023 · Sep 30, 2022 $11.73M
Rd Expense Q3 2023 · Sep 30, 2023 $26.91M
Rd Expense Q3 2023 · Sep 30, 2023 $85.1M
Rd Expense Q3 2023 · Sep 30, 2022 $20.8M
Rd Expense Q3 2023 · Sep 30, 2022 $54.11M
Net Income Q3 2023 · Sep 30, 2023 −$24.77M
Net Income Q3 2023 · Sep 30, 2023 −$66.72M
Net Income Q3 2023 · Jun 30, 2023 −$25.41M
Net Income Q3 2023 · Mar 31, 2023 −$16.53M
Net Income Q3 2023 · Sep 30, 2022 −$24.01M
Net Income Q3 2023 · Sep 30, 2022 −$64.97M
Net Income Q3 2023 · Jun 30, 2022 −$24.58M
Net Income Q3 2023 · Mar 31, 2022 −$16.38M
Operating Income Q3 2023 · Sep 30, 2023 −$29.63M
Operating Income Q3 2023 · Sep 30, 2023 −$83.59M
Operating Income Q3 2023 · Sep 30, 2022 −$24.64M
Operating Income Q3 2023 · Sep 30, 2022 −$65.84M
Revenue Q3 2023 · Sep 30, 2023 $2.79M
Revenue Q3 2023 · Sep 30, 2023 $17.11M
Revenue Q3 2023 · Sep 30, 2022 $0
Revenue Q3 2023 · Sep 30, 2022 $0